{"id":17,"date":"2017-07-26T21:11:17","date_gmt":"2017-07-26T21:11:17","guid":{"rendered":"https:\/\/wp.uthscsa.edu\/hematology\/?page_id=17"},"modified":"2025-06-25T12:43:08","modified_gmt":"2025-06-25T17:43:08","slug":"fellowship","status":"publish","type":"page","link":"https:\/\/lsom.uthscsa.edu\/hematology\/fellowship\/","title":{"rendered":"Fellowship"},"content":{"rendered":"

[vc_row el_class=”roomy”][vc_column width=”2\/3″][vc_column_text]<\/p>\n

Overview<\/h3>\n

The Hematology\/Oncology Fellowship Program is a three-year program with training in both clinical and translational research. The clinical training qualifies fellows for board certification in both hematology and oncology. The first year for most fellows consists of clinical rotations, including dedicated outpatient rotations, inpatient hematology and oncology consultations, inpatient leukemia\/lymphoma service, bone marrow transplantation, and electives. The second and third years are more flexible and are tailored to the specific interests of the individual fellows, involving approximately three months of patient-directed training each year with the remainder of the time devoted to academic research.<\/span><\/p>\n

All first-year fellows attend two clinics per week. One clinic is devoted to patients with benign or malignant hematological disorders. The other clinic is a “continuity experience” for patients with a variety of solid tumors. Second and third-year fellows have one or two clinics depending on their career goals. Second and third-year fellows spend most of their time on clinical or translational research under the guidance of faculty mentors.<\/span><\/p>\n

This program provides preparation for dual certification in hematology and oncology. At the end of training, graduates will be well qualified to pursue academic careers and independent biomedical research.<\/span><\/p>\n

Application for the program should be made in the second year of the applicant\u2019s house staff training. Applications should be submitted before the end of December, to ERAS (Electronic Residency Application Service) one and a half to 2 years before matriculation is desired. We participate in the Medical Specialty Matching Program (MSMP).<\/span><\/p>\n

Curriculum<\/h3>\n

Fellows participate in weekly hematology, and medical oncology lecture series, journal clubs, translational and basic-science seminars, and special series of small-group discussions that encompass topics dealing with communication skills, performance and quality improvement, professionalism, cancer-care, and humanistic qualities important for a career in hematology\/oncology. Multidisciplinary tumor boards cover all aspects of malignant hematology and subspecialty medical oncology care.<\/span><\/p>\n

Active-learning seminars cover basic science topics related to hematology-oncology, and clinical trials methodology and trial-design.<\/span><\/p>\n

The hematology and medical oncology fellowship curriculum incorporates the curricula recommended by the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO). It is revised frequently to reflect the rapid advances in our fields, to keep pace with the changes to graduate medical education standards, and most importantly to offer innovative approaches to learn hematology and medical oncology. The fellowship program effectively partners with ASH and ASCO in promoting education and research opportunities for fellows.<\/span>[\/vc_column_text][\/vc_column][vc_column width=”1\/3″]\n

\n
\n
<\/i><\/span><\/div>\n

Fellowship Quicklinks<\/h2>\n <\/div>\n
<\/p>\n